Home » Author Archive

Image for Denali Therapeutics Inc. (NASDAQ:DNLI) Given Consensus Recommendation of “Moderate Buy” by Analysts

Denali Therapeutics Inc. (NASDAQ:DNLI) Given Consensus Recommendation of “Moderate Buy” by Analysts

Shares of Denali Therapeutics Inc. (NASDAQ:DNLI – Get Free Report) have been assigned an average rating of “Moderate Buy” from the fourteen research firms that are presently covering the company, Marketbeat reports.... More of this article »
Image for Packaging Corporation of America (NYSE:PKG) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Packaging Corporation of America (NYSE:PKG) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Shares of Packaging Corporation of America (NYSE:PKG – Get Free Report) have earned a consensus rating of “Moderate Buy” from the nine ratings firms that are covering the company, Marketbeat reports. Five investment... More of this article »
Image for Payoneer Global Inc. (NASDAQ:PAYO) Receives Average Rating of “Moderate Buy” from Analysts

Payoneer Global Inc. (NASDAQ:PAYO) Receives Average Rating of “Moderate Buy” from Analysts

Payoneer Global Inc. (NASDAQ:PAYO – Get Free Report) has received an average recommendation of “Moderate Buy” from the eight analysts that are currently covering the firm, Marketbeat reports. One investment analyst... More of this article »
Image for The Bank of Nova Scotia (TSE:BNS) Receives Consensus Rating of “Hold” from Brokerages

The Bank of Nova Scotia (TSE:BNS) Receives Consensus Rating of “Hold” from Brokerages

Shares of The Bank of Nova Scotia (TSE:BNS – Get Free Report) (NYSE:BNS) have been given an average rating of “Hold” by the eleven ratings firms that are covering the stock, Marketbeat Ratings reports. Ten research... More of this article »
Image for Patrick Industries, Inc. (NASDAQ:PATK) Given Consensus Rating of “Moderate Buy” by Brokerages

Patrick Industries, Inc. (NASDAQ:PATK) Given Consensus Rating of “Moderate Buy” by Brokerages

Patrick Industries, Inc. (NASDAQ:PATK – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the nine analysts that are covering the firm, MarketBeat reports. Two equities research... More of this article »
Image for AMN Healthcare Services Inc (NYSE:AMN) Given Average Rating of “Hold” by Analysts

AMN Healthcare Services Inc (NYSE:AMN) Given Average Rating of “Hold” by Analysts

AMN Healthcare Services Inc (NYSE:AMN – Get Free Report) has been assigned a consensus rating of “Hold” from the nine brokerages that are covering the company, MarketBeat.com reports. Two research analysts have rated... More of this article »
Image for Elanco Animal Health Incorporated (NYSE:ELAN) Given Average Rating of “Moderate Buy” by Brokerages

Elanco Animal Health Incorporated (NYSE:ELAN) Given Average Rating of “Moderate Buy” by Brokerages

Shares of Elanco Animal Health Incorporated (NYSE:ELAN – Get Free Report) have been given a consensus rating of “Moderate Buy” by the twelve research firms that are covering the company, Marketbeat reports. One equities... More of this article »
Image for Keurig Dr Pepper, Inc (NASDAQ:KDP) Receives Consensus Rating of “Moderate Buy” from Brokerages

Keurig Dr Pepper, Inc (NASDAQ:KDP) Receives Consensus Rating of “Moderate Buy” from Brokerages

Keurig Dr Pepper, Inc (NASDAQ:KDP – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the seventeen brokerages that are presently covering the company, MarketBeat Ratings reports. One... More of this article »
Image for HF Sinclair Corporation (NYSE:DINO) Receives Average Recommendation of “Hold” from Brokerages

HF Sinclair Corporation (NYSE:DINO) Receives Average Recommendation of “Hold” from Brokerages

Shares of HF Sinclair Corporation (NYSE:DINO – Get Free Report) have been given an average recommendation of “Hold” by the fifteen analysts that are currently covering the company, MarketBeat.com reports. One equities... More of this article »
Image for CAVA Group, Inc. (NYSE:CAVA) Receives Average Rating of “Moderate Buy” from Analysts

CAVA Group, Inc. (NYSE:CAVA) Receives Average Rating of “Moderate Buy” from Analysts

Shares of CAVA Group, Inc. (NYSE:CAVA – Get Free Report) have received a consensus rating of “Moderate Buy” from the twenty-five ratings firms that are presently covering the stock, Marketbeat reports. Ten analysts... More of this article »
Image for BrightSpring Health Services, Inc. (NASDAQ:BTSG) Given Average Rating of “Buy” by Analysts

BrightSpring Health Services, Inc. (NASDAQ:BTSG) Given Average Rating of “Buy” by Analysts

Shares of BrightSpring Health Services, Inc. (NASDAQ:BTSG – Get Free Report) have been given an average rating of “Buy” by the sixteen brokerages that are currently covering the stock, MarketBeat reports. One analyst... More of this article »
Image for Definium Therapeutics, Inc. (NASDAQ:DFTX) Given Average Recommendation of “Buy” by Analysts

Definium Therapeutics, Inc. (NASDAQ:DFTX) Given Average Recommendation of “Buy” by Analysts

Shares of Definium Therapeutics, Inc. (NASDAQ:DFTX – Get Free Report) have been given an average recommendation of “Buy” by the twelve ratings firms that are presently covering the firm, Marketbeat.com reports. One... More of this article »
Image for Merit Medical Systems, Inc. (NASDAQ:MMSI) Given Average Rating of “Moderate Buy” by Analysts

Merit Medical Systems, Inc. (NASDAQ:MMSI) Given Average Rating of “Moderate Buy” by Analysts

Merit Medical Systems, Inc. (NASDAQ:MMSI – Get Free Report) has received an average rating of “Moderate Buy” from the eleven ratings firms that are presently covering the company, MarketBeat Ratings reports. Three... More of this article »
Image for Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target Raised to $641.00 at HC Wainwright

Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target Raised to $641.00 at HC Wainwright

Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its price objective lifted by HC Wainwright from $591.00 to $641.00 in a research report released on Tuesday,Benzinga reports. The brokerage currently has a buy rating on... More of this article »
Image for Bunzl (LON:BNZL) Receives “Sector perform” Rating from Royal Bank Of Canada

Bunzl (LON:BNZL) Receives “Sector perform” Rating from Royal Bank Of Canada

Royal Bank Of Canada reissued their sector perform rating on shares of Bunzl (LON:BNZL – Free Report) in a report issued on Tuesday, Marketbeat reports. The brokerage currently has a GBX 2,200 price objective on the stock. Bunzl... More of this article »
Image for Weekly Research Analysts’ Ratings Updates for Hudson Technologies (HDSN)

Weekly Research Analysts’ Ratings Updates for Hudson Technologies (HDSN)

Several analysts have recently updated their ratings and price targets for Hudson Technologies (NASDAQ: HDSN): 3/6/2026 – Hudson Technologies had its price target lowered by Canaccord Genuity Group Inc. from $10.00 to $9.50.... More of this article »
Image for Weekly Research Analysts’ Ratings Changes for PubMatic (PUBM)

Weekly Research Analysts’ Ratings Changes for PubMatic (PUBM)

Several brokerages have updated their recommendations and price targets on shares of PubMatic (NASDAQ: PUBM) in the last few weeks: 2/28/2026 – PubMatic was upgraded by Wall Street Zen from “sell” to “hold”. 2/27/2026... More of this article »
Image for Ondas (NASDAQ:ONDS) Given Buy Rating at Needham & Company LLC

Ondas (NASDAQ:ONDS) Given Buy Rating at Needham & Company LLC

Needham & Company LLC reaffirmed their buy rating on shares of Ondas (NASDAQ:ONDS – Free Report) in a research report sent to investors on Tuesday morning,Benzinga reports. Needham & Company LLC currently has a $17.00... More of this article »
Image for Vistry Group (LON:VTY) Price Target Cut to GBX 530 by Analysts at JPMorgan Chase & Co.

Vistry Group (LON:VTY) Price Target Cut to GBX 530 by Analysts at JPMorgan Chase & Co.

Vistry Group (LON:VTY – Free Report) had its price objective lowered by JPMorgan Chase & Co. from GBX 640 to GBX 530 in a research note issued to investors on Tuesday morning, MarketBeat Ratings reports. The brokerage currently... More of this article »
Image for ALX Oncology’s (ALXO) “Buy” Rating Reaffirmed at HC Wainwright

ALX Oncology’s (ALXO) “Buy” Rating Reaffirmed at HC Wainwright

HC Wainwright reissued their buy rating on shares of ALX Oncology (NASDAQ:ALXO – Free Report) in a research note issued to investors on Tuesday morning,Benzinga reports. HC Wainwright currently has a $4.00 target price on the... More of this article »
Image for Spruce Biosciences (NASDAQ:SPRB) Given “Buy” Rating at HC Wainwright

Spruce Biosciences (NASDAQ:SPRB) Given “Buy” Rating at HC Wainwright

HC Wainwright reissued their buy rating on shares of Spruce Biosciences (NASDAQ:SPRB – Free Report) in a research note released on Tuesday,Benzinga reports. They currently have a $200.00 price target on the stock. A number of... More of this article »
Image for Greggs (LON:GRG) Given New GBX 1,830 Price Target at Royal Bank Of Canada

Greggs (LON:GRG) Given New GBX 1,830 Price Target at Royal Bank Of Canada

Greggs (LON:GRG – Free Report) had its price target lowered by Royal Bank Of Canada from GBX 1,970 to GBX 1,830 in a research note issued to investors on Tuesday, MarketBeat.com reports. Royal Bank Of Canada currently has an... More of this article »
Image for SolarEdge Technologies (NASDAQ:SEDG) Upgraded by Bank of America to “Neutral” Rating

SolarEdge Technologies (NASDAQ:SEDG) Upgraded by Bank of America to “Neutral” Rating

Bank of America upgraded shares of SolarEdge Technologies (NASDAQ:SEDG – Free Report) from an underperform rating to a neutral rating in a research note issued to investors on Tuesday, MarketBeat reports. Bank of America currently... More of this article »
Image for SAB Biotherapeutics (NASDAQ:SABS) Given New $7.00 Price Target at HC Wainwright

SAB Biotherapeutics (NASDAQ:SABS) Given New $7.00 Price Target at HC Wainwright

SAB Biotherapeutics (NASDAQ:SABS – Free Report) had its price target cut by HC Wainwright from $9.00 to $7.00 in a research note released on Tuesday,Benzinga reports. They currently have a buy rating on the stock. Several other... More of this article »
Image for Foghorn Therapeutics (NASDAQ:FHTX) Given Buy Rating at HC Wainwright

Foghorn Therapeutics (NASDAQ:FHTX) Given Buy Rating at HC Wainwright

HC Wainwright reissued their buy rating on shares of Foghorn Therapeutics (NASDAQ:FHTX – Free Report) in a research note published on Tuesday,Benzinga reports. They currently have a $13.00 price objective on the stock. A number... More of this article »
Image for Deutsche Bank Aktiengesellschaft Issues Positive Forecast for Xenon Pharmaceuticals (NASDAQ:XENE) Stock Price

Deutsche Bank Aktiengesellschaft Issues Positive Forecast for Xenon Pharmaceuticals (NASDAQ:XENE) Stock Price

Xenon Pharmaceuticals (NASDAQ:XENE – Free Report) had its target price boosted by Deutsche Bank Aktiengesellschaft from $56.00 to $90.00 in a research report released on Tuesday morning,Benzinga reports. Deutsche Bank Aktiengesellschaft... More of this article »
Image for Xenon Pharmaceuticals (NASDAQ:XENE) Price Target Raised to $74.00 at HC Wainwright

Xenon Pharmaceuticals (NASDAQ:XENE) Price Target Raised to $74.00 at HC Wainwright

Xenon Pharmaceuticals (NASDAQ:XENE – Free Report) had its price objective upped by HC Wainwright from $53.00 to $74.00 in a research note issued to investors on Tuesday morning,Benzinga reports. The brokerage currently has a... More of this article »
Image for Diageo (LON:DGE) Insider Nik Jhangiani Buys 10 Shares of Stock

Diageo (LON:DGE) Insider Nik Jhangiani Buys 10 Shares of Stock

Diageo plc (LON:DGE – Get Free Report) insider Nik Jhangiani bought 10 shares of Diageo stock in a transaction on Tuesday, March 10th. The shares were acquired at an average price of GBX 1,519 per share, for a total transaction... More of this article »
Image for Entain (LON:ENT) Given New GBX 1,100 Price Target at Citigroup

Entain (LON:ENT) Given New GBX 1,100 Price Target at Citigroup

Entain (LON:ENT – Free Report) had its target price decreased by Citigroup from GBX 1,150 to GBX 1,100 in a report published on Tuesday, Marketbeat Ratings reports. Citigroup currently has a buy rating on the stock. Several other... More of this article »
Image for Progressive (NYSE:PGR) Given New $308.00 Price Target at Bank of America

Progressive (NYSE:PGR) Given New $308.00 Price Target at Bank of America

Progressive (NYSE:PGR – Free Report) had its price objective trimmed by Bank of America from $315.00 to $308.00 in a research note issued to investors on Tuesday morning,Benzinga reports. The brokerage currently has a buy rating... More of this article »
Image for USA Compression Partners (NYSE:USAC) Raised to “Strong-Buy” at Texas Capital

USA Compression Partners (NYSE:USAC) Raised to “Strong-Buy” at Texas Capital

USA Compression Partners (NYSE:USAC – Get Free Report) was upgraded by research analysts at Texas Capital from a “hold” rating to a “strong-buy” rating in a research report issued to clients and investors... More of this article »
Image for The Sage Group (LON:SGE) Price Target Lowered to GBX 1,150 at Citigroup

The Sage Group (LON:SGE) Price Target Lowered to GBX 1,150 at Citigroup

The Sage Group (LON:SGE – Free Report) had its price target decreased by Citigroup from GBX 1,400 to GBX 1,150 in a report published on Tuesday, MarketBeat Ratings reports. Citigroup currently has a buy rating on the stock. Several... More of this article »
Image for TELUS (NYSE:TU) Rating Increased to Buy at Bank of America

TELUS (NYSE:TU) Rating Increased to Buy at Bank of America

Bank of America upgraded shares of TELUS (NYSE:TU – Free Report) (TSE:T) from a neutral rating to a buy rating in a research report report published on Tuesday morning, MarketBeat reports. Bank of America currently has $16.00... More of this article »
Image for Real Estate Credit Investments (LON:RECI) Insider Acquires £12,065 in Stock

Real Estate Credit Investments (LON:RECI) Insider Acquires £12,065 in Stock

Real Estate Credit Investments Limited (LON:RECI – Get Free Report) insider Andreas Tautscher purchased 9,500 shares of the business’s stock in a transaction dated Tuesday, March 10th. The stock was bought at an average... More of this article »
Image for Repay (NASDAQ:RPAY) Price Target Lowered to $6.00 at Benchmark

Repay (NASDAQ:RPAY) Price Target Lowered to $6.00 at Benchmark

Repay (NASDAQ:RPAY – Free Report) had its target price trimmed by Benchmark from $8.00 to $6.00 in a research note issued to investors on Tuesday morning,Benzinga reports. The brokerage currently has a buy rating on the stock. RPAY... More of this article »
Image for Investment Analysts’ Weekly Ratings Changes for Rocket Pharmaceuticals (RCKT)

Investment Analysts’ Weekly Ratings Changes for Rocket Pharmaceuticals (RCKT)

Several analysts have recently updated their ratings and price targets for Rocket Pharmaceuticals (NASDAQ: RCKT): 3/8/2026 – Rocket Pharmaceuticals was downgraded by Wall Street Zen from “hold” to “sell”. 3/2/2026... More of this article »
Image for Climb Bio (NASDAQ:CLYM) Given New $15.00 Price Target at HC Wainwright

Climb Bio (NASDAQ:CLYM) Given New $15.00 Price Target at HC Wainwright

Climb Bio (NASDAQ:CLYM – Free Report) had its target price hoisted by HC Wainwright from $11.00 to $15.00 in a research note published on Tuesday morning,Benzinga reports. They currently have a buy rating on the stock. A number... More of this article »
Image for Head-To-Head Contrast: JD.com (NASDAQ:JD) & RideNow Group (NASDAQ:RDNW)

Head-To-Head Contrast: JD.com (NASDAQ:JD) & RideNow Group (NASDAQ:RDNW)

JD.com (NASDAQ:JD – Get Free Report) and RideNow Group (NASDAQ:RDNW – Get Free Report) are both retail/wholesale companies, but which is the superior stock? We will contrast the two businesses based on the strength of their... More of this article »
Image for Immunome (IMNM) to Release Earnings on Wednesday

Immunome (IMNM) to Release Earnings on Wednesday

Immunome (NASDAQ:IMNM – Get Free Report) is projected to issue its Q4 2025 results before the market opens on Wednesday, March 18th. Analysts expect the company to announce earnings of ($0.64) per share and revenue of $0.7850... More of this article »
Image for Hims & Hers Health Sees Unusually Large Options Volume (NYSE:HIMS)

Hims & Hers Health Sees Unusually Large Options Volume (NYSE:HIMS)

Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) saw unusually large options trading activity on Wednesday. Stock traders bought 322,282 call options on the company. This is an increase of 128% compared to the average... More of this article »
Image for Corporacion America Airports (CAAP) to Release Earnings on Wednesday

Corporacion America Airports (CAAP) to Release Earnings on Wednesday

Corporacion America Airports (NYSE:CAAP – Get Free Report) is projected to release its Q4 2025 results before the market opens on Wednesday, March 18th. Analysts expect the company to announce earnings of $0.45 per share and... More of this article »
Image for Williams-Sonoma (WSM) Projected to Post Earnings on Wednesday

Williams-Sonoma (WSM) Projected to Post Earnings on Wednesday

Williams-Sonoma (NYSE:WSM – Get Free Report) is projected to issue its Q4 2026 results before the market opens on Wednesday, March 18th. Analysts expect the company to announce earnings of $2.89 per share and revenue of $2.4098... More of this article »
Image for Precigen (PGEN) to Release Quarterly Earnings on Wednesday

Precigen (PGEN) to Release Quarterly Earnings on Wednesday

Precigen (NASDAQ:PGEN – Get Free Report) is expected to be issuing its Q4 2025 results before the market opens on Wednesday, March 18th. Analysts expect the company to announce earnings of ($0.10) per share and revenue of $8.2860... More of this article »
Image for Perpetua Resources (PPTA) Expected to Announce Quarterly Earnings on Wednesday

Perpetua Resources (PPTA) Expected to Announce Quarterly Earnings on Wednesday

Perpetua Resources (NASDAQ:PPTA – Get Free Report) is expected to be announcing its Q4 2025 results before the market opens on Wednesday, March 18th. Analysts expect the company to announce earnings of ($0.01) per share for... More of this article »
Image for LENZ Therapeutics (LENZ) Projected to Post Earnings on Wednesday

LENZ Therapeutics (LENZ) Projected to Post Earnings on Wednesday

LENZ Therapeutics (NASDAQ:LENZ – Get Free Report) is expected to release its Q4 2025 results before the market opens on Wednesday, March 18th. Analysts expect LENZ Therapeutics to post earnings of ($0.91) per share and revenue... More of this article »
Image for Kingsoft Cloud (KC) Projected to Post Quarterly Earnings on Wednesday

Kingsoft Cloud (KC) Projected to Post Quarterly Earnings on Wednesday

Kingsoft Cloud (NASDAQ:KC – Get Free Report) is expected to post its Q4 2025 results before the market opens on Wednesday, March 18th. Analysts expect the company to announce earnings of ($0.05) per share and revenue of $396.8070... More of this article »
Image for Alumis (ALMS) to Release Earnings on Wednesday

Alumis (ALMS) to Release Earnings on Wednesday

Alumis (NASDAQ:ALMS – Get Free Report) is anticipated to announce its Q4 2025 results before the market opens on Wednesday, March 18th. Analysts expect Alumis to post earnings of ($0.90) per share and revenue of $2.75 million... More of this article »
Image for Western Copper and Gold (WRN) Expected to Announce Quarterly Earnings on Wednesday

Western Copper and Gold (WRN) Expected to Announce Quarterly Earnings on Wednesday

Western Copper and Gold (NYSEAMERICAN:WRN – Get Free Report) (TSE:WRN) is projected to post its results before the market opens on Wednesday, March 18th. Analysts expect Western Copper and Gold to post earnings of ($0.01) per... More of this article »
Image for General Mills (GIS) Projected to Post Earnings on Wednesday

General Mills (GIS) Projected to Post Earnings on Wednesday

General Mills (NYSE:GIS – Get Free Report) is expected to release its Q3 2026 Prepared Remarks results before the market opens on Wednesday, March 18th. Analysts expect the company to announce earnings of $0.84 per share and... More of this article »
Image for Sera Prognostics (SERA) Expected to Announce Quarterly Earnings on Wednesday

Sera Prognostics (SERA) Expected to Announce Quarterly Earnings on Wednesday

Sera Prognostics (NASDAQ:SERA – Get Free Report) will likely be announcing its Q4 2025 results after the market closes on Wednesday, March 18th. Analysts expect the company to announce earnings of ($0.17) per share and revenue... More of this article »